Editor-in-Chief
Hatice Kübra Elçioğlu
Vice Editors
Levent Kabasakal
Esra Tatar
Online ISSN
2630-6344
Publisher
Marmara University
Frequency
Bimonthly (Six issues / year)
Abbreviation
J.Res.Pharm.
Former Name
Marmara Pharmaceutical Journal
Journal of Research in Pharmacy
2024 , Vol 28 , Issue 1
In silico PASS prediction and evaluation of antitumor and anti-angiogenic activity of peel extracts of Citrus karna Raf. fruit
1Centre for Research in Pharmaceutical Sciences, Sharda Bhavan Education Society's Nanded Pharmacy College, Nanded 431605, Maharashtra, India
DOI :
10.29228/jrp.702
Inhibition of angiogenesis is one of the significant contrivance to suppress the developing
tumor. Several previous studies have shown that phytochemicals can modify numerous vital processes of
tumor promotion. However, there is no literature evidence of investigation on antitumor and antiangiogenic
activity of Citrus karna Raf. fruit. It is used as folklore medicine for the treatment of various
conditions like diabetic complications, gastro-intestinal disorders and neurological complication by the
rural peoples in India. The present study was performed to investigate antitumor and antiangiogenic
activity of Citrus Karna Raf. fruit peel. Among the different extracts, the CKME showed strong in vitro
cytotoxic activity on Human Lung Cancer Cell line Hop2 and Human Hepatoma Cell line HepG2 in SRB
assay. In Chick embryo chorioallantoic membrane (CAM) assay, angiogenesis processes is strongly
inhibited by CKME and chrysin at 100 μg/disc. The formation of blood vessels is essential for fulfilling
tumor growth requirements and transport of metastatically competent tumor cells that was reduced by
CKME and chrysin. In silico PASS prediction showed that of Citrus Karna Raf. contains several
phytochemicals that exhibit anticancer active by different mechanisms like inhibition of TNF expression
and stimulation of apoptosis. In conclusion, the components of CKME are promising candidates for cancer
treatment and further experimental investigations are needed in order to confirm their mechanism of action.
Keywords :
Antitumor drug screening assays; Antitumor agents; Angiogenesis inhibitors; CAM Assay; SRB Assay; Citrus Karna Raf